Corbus Pharmaceuticals to present at RBC and Jefferies healthcare conferences in May and June 2026

Corbus Pharmaceuticals Holdings, a clinical-stage biotech company focused on oncology and obesity therapies, announced CEO Yuval Cohen will present corporate updates and meet investors at two major healthcare conferences in New York: the RBC Capital Markets Global Healthcare Conference on May 19, 2026, and the Jefferies Global Healthcare Conference on June 4, 2026. These presentations provide Corbus an opportunity to showcase its pipeline, including CRB-701 for cancer and CRB-913 for obesity, to potential investors and partners. The events are webcast, allowing broader access to the company's strategic outlook and progress. This engagement highlights Corbus's efforts to advance its clinical programs and attract investment ahead of key regulatory and trial milestones.